The Lung As an Alternative Route of Delivery for Insulin in Controlling Postprandial Glucose Levels in Patients with Diabetes

Chest

Volumn 114, Issue 6, 1998, Pages 1734-1739

  Laube, Beth L ^a   Benedict, G William ^b   Dobs, Adrian S ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aerosol; Diabetes; Insulin; Lungs; Postprandial glucose

Indexed keywords

INSULIN;

ADULT; AEROSOL; AGED; ARTICLE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEBULIZER; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; POSTPRANDIAL STATE;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PILOT PROJECTS; POSTPRANDIAL PERIOD;

EID: 0032240027     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.6.1734     Document Type: Article

References (18)

1. Cresia DA, Saviolakis GA, Bostian HA. Efficacy of inhaled insulin: effect of adjuvant [abstract]. FASEB J 1988; 2:A537
2. Almer L-O, Troedsson A, Arborelius M Jr, et al. Insulin inhalation - at last a breakthrough. Diabetes Res Clin Pract Suppl 1988; 5:S163
3. Jendle JH, Karlberg BE, Arborelius M Jr. An exploration of intrapulmonary insulin administration in anaesthetized and mechanically ventilated pigs. Scand J Clin Lab Invest 1996; 56:251-258
4. Gaensslen M. Über inhalation von Insulin. Klin Wochenschr 1925; 2:71-72
5. Wigley FM, Londono JH, Wood SH, et al. Insulin across respiratory mucosae by aerosol delivery. Diabetes 1971; 20:552-556
6. Elliott RB, Edgar BW, Pilcher CC, et al. Parenteral absorption of insulin from the lung in diabetic children. Aust Paediatr J 1987; 23:293-297
7. Jendle JH, Karlberg BE. Intrapulmonary administration of insulin to healthy volunteers. J Intern Med 1996; 240: 93-98
8. Kohler D, Schluter KJ, Kerp L, et al. Nicht radioaktives verfahren zur messung der lungenpermeabilitat: inhalation von insulin. Atemw Lungenkrkh 1987; 13:230-232
9. Laube BL, Georgopoulos A, Adams GK III. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA 1993; 269: 2106-2109
10. Galloway JA, Chance RE, Su KSE. Human insulin and its modifications. In: Reidenberg MM, ed. The clinical pharmacology of biotechnology products. Amsterdam: Elsevier Science Publishers, 1991; 23-34
11. Howey DC, Hooper SA, Bowsher RR. [Lys(B28), Pro(B29)]-human insulin: an equipotent analogue of human insulin with rapid onset and short duration of action [abstract]. Diabetes 1991; 40(suppl 1):A1688
12. Zinman B. Drug therapy: the physiologic replacement of insulin. N Engl J Med 1989; 321:363-370
13. Salzman R, Manson JE, Griffing GT. Intranasal aerosolized insulin. N Engl J Med 1985; 312:1078-1084
14. Colthorpe P, Farr SJ, Taylor G, et al. The pharmacokinetics of pulmonary delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit. Pharm Res 1992; 9:764-768
15. Laube BL, Swift DL, Wagner HN Jr, et al. The effect of bronchial obstruction on central airway deposition of a saline aerosol in patients with asthma. Am Rev Respir Dis 1986; 133:740-743
16. Dolovich MB, Sanchis J, Rossman C, et al. Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol 1976; 40:468-471
17. Chung KF, Snashall PD, Jeyasingh K. Influence of airway calibre on the interpulmonary dose and distribution of inhaled aerosol in normal and asthmatic subjects. Eur Respir J 1988; 1:890-895
18. Laube BL, Benedict GW, Dobs AS. Time to peak insulin level, relative bioavailability and effect of site of deposition of nebulized insulin in patients with non-insulin dependent diabetes mellitus. J Aerosol Med 1998; 11:153-173